Elon Musk revealed that he recently used his own AI chatbot, Grok, to analyze his MRI results, demonstrating a growing trend of AI applications in medical diagnostics. During an interview with podcaster and Harvard-educated doctor Peter Diamandis on the “Moonshots” podcast posted Tuesday, the xAI CEO disclosed that he underwent an MRI and subsequently uploaded the results to Grok for analysis. “I did an MRI recently and submitted it to Grok,” Musk stated, adding that “None of the doctors nor Grok found anything.”
The revelation comes just a week after Musk publicly encouraged people to try uploading their medical results to Grok, citing a case where the AI chatbot potentially saved a Norwegian man’s life. According to Musk, the man posted on Reddit that Grok identified a missed diagnosis and encouraged him to return to the hospital for a CT scan, which confirmed his appendix was close to rupturing. “Try it!” Musk wrote on X, promoting the AI’s medical diagnostic capabilities.
The discussion with Diamandis, founder of XPrize, underscores the intersection of AI development and longevity research that has captivated Silicon Valley’s tech elite. Across the industry, billionaires including OpenAI’s Sam Altman and Peter Thiel are investing millions in research to combat aging and extend human lifespan. In 2024, Anthropic CEO Dario Amodei made the bold prediction that AI could double life expectancy by 2030.
During a February 2025 appearance on Joe Rogan’s podcast, Musk expressed confidence that AI would be “very good” at helping with medical diagnoses, a statement he’s now backing up with personal use. However, Musk also shared philosophical reservations about extreme longevity, calling true immortality “one of the worst curses you could possibly give anyone.”
Despite this, the Tesla and SpaceX CEO believes solving aging is “an extremely solvable problem” and “not a particularly hard problem,” noting that the body’s synchronized aging suggests the biological clock “must be incredibly obvious.” Diamandis pitched Musk on collaborating with Fountain Life, a longevity company offering “AI-guided diagnostics” that test for biomarkers. The company performs comprehensive health assessments including “a 200 gigabyte upload of you, everything knowable about you, full genome, all imaging, everything,” according to Diamandis, who urged Musk not “to pull a Steve Jobs” — a reference to Apple’s founder who died in 2011 after delaying cancer treatment.
Key Quotes
I did an MRI recently and submitted it to Grok. None of the doctors nor Grok found anything.
Elon Musk revealed during his interview with Peter Diamandis that he personally used his company’s AI chatbot to analyze his medical imaging results, demonstrating confidence in AI diagnostic capabilities and setting an example for public adoption of AI healthcare tools.
I’ve long thought that longevity or semi-mortality is an extremely solvable problem. I don’t think it’s a particularly hard problem. I mean, when you consider the fact that your body is extremely synchronized in its age, the clock must be incredibly obvious.
Musk expressed his belief that AI and technology could unlock the secrets to extending human lifespan, reflecting the broader Silicon Valley trend of investing heavily in longevity research and the role AI might play in understanding biological aging mechanisms.
Try it!
Musk encouraged X users to upload their medical results to Grok after citing a case where the AI chatbot allegedly saved a Norwegian man’s life by identifying a near-rupturing appendix that doctors had missed, actively promoting AI as a medical diagnostic tool.
We do a 200 gigabyte upload of you, everything knowable about you, full genome, all imaging, everything.
Peter Diamandis described the comprehensive AI-guided diagnostic approach used by Fountain Life, his longevity company, illustrating how AI is being integrated into preventive medicine and personalized health monitoring at the highest levels of tech entrepreneurship.
Our Take
Musk’s public endorsement of Grok for medical diagnosis is both groundbreaking and controversial. While AI has shown impressive capabilities in medical imaging analysis in controlled research settings, using consumer-facing chatbots for personal health decisions represents uncharted regulatory territory. The anecdotal success story Musk cited raises important questions: How many cases has Grok analyzed? What’s its accuracy rate? What happens when AI provides incorrect medical advice? This move could pressure regulators to establish clearer guidelines for AI medical applications while simultaneously pushing competitors like OpenAI and Google to enhance their own health-focused AI capabilities. The convergence of AI diagnostics with longevity research signals a paradigm shift where tech billionaires aren’t just building AI systems—they’re using them to pursue radical life extension. This personal stake may accelerate AI healthcare development but also highlights the growing divide between those with access to cutting-edge AI medical tools and those without.
Why This Matters
This story represents a significant milestone in AI’s practical application to healthcare and medical diagnostics. When one of the world’s most prominent tech leaders publicly uses and endorses AI for personal medical analysis, it signals growing confidence in AI’s diagnostic capabilities and could accelerate mainstream adoption. The incident highlights the rapid evolution of large language models beyond text generation into specialized domains like medical imaging interpretation.
The broader implications extend to healthcare accessibility and the democratization of medical expertise. If AI chatbots can accurately analyze medical imaging and identify missed diagnoses, they could serve as valuable second-opinion tools, particularly in underserved areas lacking specialist access. However, this also raises critical questions about medical liability, regulatory oversight, and the appropriate role of AI in clinical decision-making. The intersection of AI development with longevity research, backed by billions in Silicon Valley funding, suggests we’re entering an era where AI could fundamentally transform not just how we diagnose disease, but how we approach aging itself. This convergence of technologies may reshape healthcare delivery and human lifespan within the next decade.
Related Stories
- Artificial Intelligence (AI) in Healthcare Market Outlook 2022 to 2028: Emerging Trends, Growth Opportunities, Revenue Analysis, Key Drivers and Restraints
- Elon Musk’s XAI Secures $6 Billion in Funding for Artificial Intelligence Research
- Sam Altman and Jony Ive Partner on AI Device, Target $1B Funding
- Elon Musk’s $97B OpenAI Bid: Strategic Move or Elaborate Troll?
- X.AI Generated Adult Content Rules and Policy Update
Source: https://www.businessinsider.com/elon-musk-mri-grok-health-ai-longevity-2026-1